A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY TO ASSESS THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN ADULT PATIENTS WITH MILD TO MODERATE ASTHMA.
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Lebrikizumab (Primary) ; Montelukast
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms STRETTO
- Sponsors Roche
- 18 May 2016 Trial design presented at the 112th International Conference of the American Thoracic Society
- 02 Apr 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 31 Dec 2015 Status changed from active, no longer recruiting to recruiting.